Recent survey points to the need for better education for COPD patients on how to use inhalers.
Chronic obstructive pulmonary disease (COPD) is a respiratory disorder that affects millions of patients and leads to substantial morbidity, mortality, disability, impaired quality of life, and increased health care costs. As the COPD Outcomes-based Network for Clinical Effectiveness & Research Translation (CONCERT) explains:
“Chronic Obstructive Pulmonary Disease (COPD) is a respiratory disorder that affects about 300 million patients worldwide and 30 million patients in the US alone. COPD carries a substantial burden in human suffering. Dyspnea and other respiratory symptoms are common and can be disabling. Respiratory infections and exposure to environmental triggers lead to episodic deteriorations (acute exacerbations of COPD; AE-COPD) and result in over 700,000 hospitalizations and 100,000 deaths each year in the U.S. alone.
Articles we have been reading this past week of May 7, 2018 focus on opioids and preventing “dead-in-bed.”
How Often Does “Dead-In-Bed” Happen in Hospitals?
The Physician-Patient Alliance for Health & Safety (PPAHS) announced its intention to develop a position statement on recommendations for procedural sedation.
Michael Wong, JD (Founder and Executive Director, PPAHS) explained that such a position statement on recommendations for procedural sedation would encapsulate guidelines and recommendations from leading medical organizations in Canada and the United States:
The number of patients – and, particularly, children – dying from dental sedation is indicative that there are gaps in the standard of medical care being used during dental sedation.
In this article by Bradley T. Truax, MD (The Truax Group) and Michael Wong, JD (Founder and Executive Director, Physician-Patient Alliance for Health & Safety), the authors discuss why dental sedation needs better standards to prevent further patient deaths and provide seven keys.
To read the article in Dentistry Today, please click here.
The Physician-Patient Alliance for Health & Safety (PPAHS) released a clinical education podcast, “Using Capnography and Recognizing Respiratory Compromise Could Save Patient Lives.”
The podcast features an interview with Jenifer Lightdale, MPH, MD who is division chief, pediatric gastroenterology and chief quality officer at the Children’s Medical Center at the University of Massachusetts Medical School.
To help identify and monitor for respiratory compromise, Canadian Society of Respiratory Therapists has launched a Respiratory Compromise Toolkit.
By Adam Buettner, RRT, FCSRT (President-Elect, Canadian Society of Respiratory Therapists) and Carolyn McCoy, BHS, RRT, FCSRT (Director of Professional Practice, Canadian Society of Respiratory Therapists)
The Canadian Society of Respiratory Therapists (CSRT) recently released a Respiratory Compromise Toolkit to help detect and prevent respiratory compromise.
With the permission of the Association for the Advancement of Medical Instrumentation (AAMI), the Physician-Patient Alliance for Health & Safety (PPAHS) is pleased to release the AAMI video on how to keep patients and their families safe, “Only Continuous Electronic Monitoring Can Ensure Patients Receiving Opioids Are Safe.”
In a clinical education podcast, Frank Overdyk, MD, who is an anesthesiologist practicing in Charleston, SC, discusses preventing avoidable deaths and the costs of monitoring patients receiving opioids and the costs of not being monitored. It is impossible to predict with 100% accuracy how a particular patient will react when administered an opioid. Continuous patient monitoring, which costs just $20-$30 per day in the case of monitoring with pulse oximetry, is a small price to pay to help prevent avoidable patient deaths.
By Michael Wong, JD (Founder/Executive Director, Physician-Patient Alliance for Health & Safety)
I recently interviewed Frank Overdyk, MD, who is an anesthesiologist practicing in Charleston, SC, about the costs of monitoring patients receiving opioids and the costs of not being monitored. Dr. Overdyk is a member of board of advisors of the Physician-Patient Alliance for Health & Safety and organized the two conferences on opioid-induced respiratory depression (“OIRD”) for the Anesthesia Patient Safety Foundation.
Researchers have found that respiratory compromise may occur with obstructive sleep apnea (OSA) patients receiving opioids.
Research conducted by Yamini Subramani, MD et al, “Death or near-death in patients with obstructive sleep apnoea: a compendium of case reports of critical complications” found 5 reasons why the risk of death is higher in patients with obstructive sleep apnea (OSA).
After removing for duplicates, the researchers analyzed more than 1,000 patient cases.
# 1 Fact – Patients can have obstructive sleep apnea and not know it
Third Most Common Cause of Avoidable Death in the United States
Respiratory compromise is the third most common cause of avoidable death in the United States.
In help recognize and better manage respiratory compromise, clinicians at Columbia University Medical Center (CUMC) discuss the need for identifying patients at risk, understanding the benefits of early intervention and respiratory monitoring to mitigate patient adverse events and deaths. To listen to the webinar, please click here.